Lyell Immunopharma
LYEL
$2.25
Share price
3.69%
Change (1 day)
5.14%
Change (1 year)
Categories
Lyell Immunopharma (LYEL) - P/B ratio
P/B ratio as of April 2024 : 0.8758
According to Lyell Immunopharma's latest financial reports the company has a price-to-book ratio of 0.8758.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Lyell Immunopharma - P/B ratio (from 2021 to 2023)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2023-12-31 | 0.7460 | -28.15% |
| 2022-12-31 | 1.04 | -48.13% |
| 2021-12-31 | 2.00 | |
| 2020-12-31 | N/A |